Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Moodys
Express Scripts
Mallinckrodt
AstraZeneca

Last Updated: May 22, 2022

TOPICORT Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

When do Topicort patents expire, and when can generic versions of Topicort launch?

Topicort is a drug marketed by Taro Pharm Inds Ltd and Taro Pharms and is included in ten NDAs. There are two patents protecting this drug and one Paragraph IV challenge.

This drug has four patent family members in four countries.

The generic ingredient in TOPICORT is desoximetasone. There are seven drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the desoximetasone profile page.

Drug patent expirations by year for TOPICORT
Drug Prices for TOPICORT

See drug prices for TOPICORT

Drug Sales Revenue Trends for TOPICORT

See drug sales revenues for TOPICORT

Recent Clinical Trials for TOPICORT

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Wake Forest University Health SciencesPhase 4
Psoriasis Treatment Center of Central New JerseyPhase 4
Taro Pharmaceuticals USAPhase 4

See all TOPICORT clinical trials

Paragraph IV (Patent) Challenges for TOPICORT
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
TOPICORT Topical Spray desoximetasone 0.25% 204141 1 2013-12-18

US Patents and Regulatory Information for TOPICORT

TOPICORT is protected by two US patents.

Patents protecting TOPICORT

Stable liquid desoximethasone compositions with reduced oxidized impurity
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF PLAQUE PSORIASIS IN PATIENTS 18 YEARS OF AGE OR OLDER

Stable liquid desoximethasone compositions with reduced oxidized impurity
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF PLAQUE PSORIASIS IN PATIENTS 18 YEARS OF AGE OR OLDER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro Pharm Inds Ltd TOPICORT desoximetasone CREAM;TOPICAL 073210-001 Nov 30, 1990 AB RX No Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Taro Pharm Inds Ltd TOPICORT desoximetasone OINTMENT;TOPICAL 074286-001 Jun 7, 1996 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Taro Pharm Inds Ltd TOPICORT desoximetasone GEL;TOPICAL 074904-001 Jul 14, 1998 AB RX No Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Taro Pharm Inds Ltd TOPICORT desoximetasone OINTMENT;TOPICAL 018763-001 Sep 30, 1983 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Taro Pharm Inds Ltd TOPICORT desoximetasone CREAM;TOPICAL 073193-001 Nov 30, 1990 AB RX No Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for TOPICORT

See the table below for patents covering TOPICORT around the world.

Country Patent Number Title Estimated Expiration
Israel 187666 הרכב נוזלי ויציב של דסוקסימטאסון ואיזופרופיל מיריסטט עם רמת זיהומים מחומצנים פחותה במהלך איחסון ארוך טווח (Stable liquid formulation comprising desoximetasone and isopropyl myristate with reduced oxidized impurity during long-term storage) See Plans and Pricing
Canada 2609579 PREPARATION LIQUIDE STABLE COMPRENANT DE LA DESOXYMETASONE ET DU MYRISTATE ISOPROPYLIQUE A TENEUR REDUITE EN IMPURETES OXYDEES EN CAS DE STOCKAGE DE LONGUE DUREE (STABLE LIQUID DESOXIMETASONE COMPOSITIONS WITH REDUCED OXIDIZED IMPURITY) See Plans and Pricing
European Patent Office 1888026 PREPARATION LIQUIDE STABLE COMPRENANT DE LA DESOXYMETASONE ET DU MYRISTATE ISOPROPYLIQUE A TENEUR REDUITE EN IMPURETES OXYDEES EN CAS DE STOCKAGE DE LONGUE DUREE (A STABLE LIQUID FORMULATION COMPRISING DESOXIMETASONE AND ISOPROPYL MYRISTATE WITH REDUCED OXIDIZED IMPURITY DURING LONG-TERM STORAGE) See Plans and Pricing
World Intellectual Property Organization (WIPO) 2006130510 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
McKinsey
Colorcon
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.